Day: March 20, 2024

Lotus Technology to Report Unaudited Fourth Quarter and Full Year 2023 Financial Results on April 8, 2024

Lotus Technology to Report Unaudited Fourth Quarter and Full Year 2023 Financial Results on April 8, 2024

NEW YORK, March 20, 2024 (GLOBE NEWSWIRE) — Lotus Technology Inc. (“Lotus Tech” or the “Company”) (Nasdaq: LOT), a leading global luxury electric vehicle maker, today announced that it will report its unaudited fourth quarter and full year 2023 financial results on April 8, 2024, before market opening in the United States. The Company’s management will host an earnings conference call at 8:00 AM U.S. Eastern Time on Monday, April 8, 2024 (14:00 Central European Time / 20:00 China Standard Time on the same day). There will be a live audio webcast and replay available following completion of the call on the Company’s investor relations website at https://ir.group-lotus.com/. For participants who wish to join the call, please complete online registration prior to the scheduled call start time using the link provided below. Upon registration,...

Continue reading

ARKO Corp. Subsidiary GPM Investments Ramps Up Hiring Initiative to Strengthen Workforce and Foster Growth – Seeking to Hire 1,500 Employees

ARKO Corp. Subsidiary GPM Investments Ramps Up Hiring Initiative to Strengthen Workforce and Foster Growth – Seeking to Hire 1,500 Employees

RICHMOND, Va., March 20, 2024 (GLOBE NEWSWIRE) — GPM Investments, LLC (“GPM”) a wholly owned subsidiary of ARKO Corp. (Nasdaq: ARKO) a Fortune 500 company and one of the largest convenience store operators in the United States, proudly announces the launch of a comprehensive hiring initiative aimed at prepping for the summer selling season. With a steadfast commitment to excellence and growth, GPM is dedicated to fostering a diverse and dynamic team to propel its mission forward. Amidst a rapidly evolving market landscape, GPM recognizes the importance of investing in top-tier talent to maintain its competitive edge and continue delivering exceptional products/services to its customers such as its new delectable pizza offering where an enrolled fas REWARDS® member can purchase a whole pizza for only $4.99. The new hiring initiative...

Continue reading

Helios Fairfax Partners Appoints Katherine Cunningham to its Board of Directors

Helios Fairfax Partners Appoints Katherine Cunningham to its Board of Directors

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES TORONTO, March 20, 2024 (GLOBE NEWSWIRE) — Helios Fairfax Partners Corporation (TSX: HFPC.U) (“HFP”) announces that it has appointed Katherine Cunningham as an independent director. Katherine Cunningham is the Chief Financial Officer at The Globe and Mail Inc., Canada’s national newspaper, where she is responsible for strategy, corporate development and all aspects of financial management. Until 2019, she was a Senior Vice President at Sun Life Financial Inc., holding SVP Finance, Chief Financial Officer Canada, and Chief Auditor roles. Prior to joining Sun Life in 2014, Ms. Cunningham was an Audit Partner at KPMG Canada LLP in the Communications and Media and, later, Financial Services industries. She is a Chartered Professional Accountant...

Continue reading

The MeridianBet - Golden Matrix Transaction Secures Approval at GMGI Shareholder Assembly

The MeridianBet – Golden Matrix Transaction Secures Approval at GMGI Shareholder Assembly

Superbowl 58 Meridianbet Odds Superbowl 58 Meridianbet Odds LAS VEGAS and VALETTA, Malta, March 20, 2024 (GLOBE NEWSWIRE) — The MeridianBet Group, Southeast Europe’s leading Business-to-Consumer (“B2C”) sports betting and gaming group, operating in multiple markets across Europe, Africa, and Latin America, is pleased to note that shareholders of Golden Matrix Group Inc, (“GMG”), a developer, licensor and global operator of online gaming and eCommerce platforms, systems, and gaming content, (NASDAQ: GMGI), have voted to approve the acquisition of MeridianBet. Commenting on the merger Zoran Milosevic, Chief Executive Officer of MeridianBet Group, said: “Today marks a major milestone for MeridianBet and I am thrilled that the shareholders of Golden Matrix have overwhelmingly voted in favor of the acquisition...

Continue reading

CVB Financial Corp. Announces 138th Consecutive Quarterly Cash Dividend

CVB Financial Corp. Announces 138th Consecutive Quarterly Cash Dividend

ONTARIO, CA, March 20, 2024 (GLOBE NEWSWIRE) — CVB Financial Corp. (NASDAQ: CVBF) (the “Company”) announced a twenty cent ($0.20) per share cash dividend with respect to the first quarter of 2024. This dividend was approved at the Company’s regularly scheduled Board of Directors meeting held on March 20, 2024. The quarterly dividend will be payable on or about April 17, 2024 to shareholders of record as of April 3, 2024. “We are pleased to announce our 138th consecutive quarterly cash dividend paid to our shareholders,” said David A. Brager, President and Chief Executive Officer. Corporate OverviewCVB Financial Corp. (“CVBF”) is the holding company for Citizens Business Bank. CVBF is one of the 10 largest bank holding companies headquartered in California with approximately $16 billion in total assets. Citizens Business Bank is...

Continue reading

<div>GitLab Acquires Oxeye to Advance Application Security & Governance Capabilities</div>

GitLab Acquires Oxeye to Advance Application Security & Governance Capabilities

Already recognized as the only Leader in Integrated Software Delivery Platforms by an independent research firm, GitLab’s DevSecOps platform combines best-in-class, robust security, governance, and AI/ML across the software development lifecycle SAN FRANCISCO, March 20, 2024 (GLOBE NEWSWIRE) — All Remote – GitLab Inc., ​​the most comprehensive AI-powered DevSecOps platform, today announced it has acquired Oxeye, the provider of an award-winning, cloud-native application security and risk management solution. With the acquisition of Oxeye, GitLab will accelerate its Static Application Security Testing (SAST) roadmap. Oxeye’s capabilities will also augment GitLab’s software composition analysis and compliance tools. Oxeye offers an automated cloud-native application security testing solution to help customers identify and resolve...

Continue reading

authID Inc. Reports Financial and Operating Results for the Fiscal Year Ended December 31, 2023

authID Inc. Reports Financial and Operating Results for the Fiscal Year Ended December 31, 2023

Momentum drives $4 million in signed contract RPO value, a 4,800% increase over 2022 Accelerates realization of the Company’s original June 2024 signed contracts bARR target of $3 million by 6 months Management to Host Conference Call Today at 5:30 p.m. EDT DENVER, March 20, 2024 (GLOBE NEWSWIRE) — authID Inc. (Nasdaq: AUID), a leading provider of innovative biometric identity verification and authentication solutions, today reported financial and operating results for the full year ended December 31, 2023. Commenting on these results, Rhon Daguro, authID CEO, said, “Our efforts in 2023—the strengthening of our financial foundation, addition of new identity domain sales and engineering talent, and application of a proven sales discipline to our engagements that generated a robust sales pipeline—have positioned authID for growth...

Continue reading

HilleVax Reports Full Year 2023 Financial Results and Highlights Recent Company Progress

HilleVax Reports Full Year 2023 Financial Results and Highlights Recent Company Progress

Topline data from NEST-IN1 Phase 2B clinical study of HIL-214 in infants expected in mid-2024 Enrollment for NEST-IN1 study completed in Q2 2023 $303.5 million of cash, cash equivalents and marketable securities as of December 31, 2023 BOSTON, March 20, 2024 (GLOBE NEWSWIRE) — HilleVax, Inc. (Nasdaq: HLVX), a clinical-stage biopharmaceutical company focused on developing and commercializing novel vaccines, today reported financial results for the year ended December 31, 2023, highlighted recent progress and outlined key upcoming milestones for HIL-214, the company’s investigational virus-like particle (VLP) based vaccine for the prevention of moderate-to-severe norovirus-related acute gastroenteritis. “Over the past year, we made significant progress with HIL-214, our vaccine candidate for the prevention of moderate-to-severe...

Continue reading

NEO Battery Materials Announces Change of Auditor to MNP LLP

NEO Battery Materials Announces Change of Auditor to MNP LLP

TORONTO, March 20, 2024 (GLOBE NEWSWIRE) — NEO Battery Materials Ltd. (“NEO” or the “Company”) (TSXV: NBM) (OTC: NBMFF), a low-cost silicon anode materials developer that enables longer-running, rapid-charging lithium-ion batteries, is pleased to announce that it has changed its auditors from DeVisser Gray LLP (“Former Auditor”) to MNP LLP (“Successor Auditor”), effective March 19, 2024. NEO Battery’s board of directors accepted the resignation of DeVisser Gray LLP and appointed MNP LLP as the new auditor of the Company, effective March 19, 2024, until the Company’s next annual general meeting of shareholders. There were no reservations in the Former Auditor’s audit reports for any financial period during which the Former Auditor was the Company’s auditor. There are no “reportable events” (as the term is defined in National Instrument...

Continue reading

Alvotech Reports Financial Results for Full Year 2023 and Provides a Business Update

Alvotech Reports Financial Results for Full Year 2023 and Provides a Business Update

Total Revenues in 2023 were $93.4 million, up 10% from previous year Product Revenues in 2023 were $48.7 million, compared to $24.8 million in 2022, with Q4 2023 product revenues of $18.9 million, up by 37% from the same period last year Alvotech’s Simlandi™ biosimilar to Humira® (adalimumab) was approved in the U.S. as the first high-concentration biosimilar with interchangeable status Sales of Alvotech’s Jamteki™ biosimilar to Stelara® (ustekinumab) started in Canada with launches expected in Japan in Q2 and Europe in Q3 Positive top-line results were announced from a confirmatory efficacy study for Alvotech’s proposed biosimilar to Eylea® (aflibercept) and PK studies for proposed biosimilars to Prolia®/Xgeva® (denosumab) and Simponi®/Simponi Aria® (golimumab) REYKJAVIK, Iceland, March 20, 2024 (GLOBE NEWSWIRE)...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.